title: Two-year results of renal transplantation in kidney recipients from > or = 65-year-old deceased donors: a French region experience.
abstract: The use of elderly deceased donors requires refining criteria for both the donor and the recipient. This report attempted to identify parameters susceptible to further improvement. This retrospective multicenter study analyzed the outcomes of kidney recipients from 15 consecutive elderly deceased donors in the south French region (IR9). Donors were 65 to 74 years old. Mean creatinine clearance was 80 mL/min/1.73 m(2). The donor risk factors for allograft dysfunction were stroke, hypertension, cardiovascular disease, cardiac death, smoking, arrhythmia, and diabetes. The recipients were 35 to 70 years old. The median cold ischemia time was 24 hours. Four patients (16%) suffered delayed graft function (DGF). Three recipients (12%) died within the first 2 months after transplantation. The postoperative complications (29%) were 2 renal artery thromboses, 4 renal artery stenoses, and 1 toe ischemia. Two years after transplantation, their mean serum creatinine was 157 micromol/L. The patient and graft survivals were 88% and 70%, respectively. These results seemed worse than those reported in the literature, but it was a small cohort and a new experience. DGF is probably linked to improvable management to reduce cold ischemia time. The elevated rate of surgical complications might be related to a lack of experience in donor and recipient evaluations. Kidney transplantation from elderly donors requires an efficient organization and an accurate evaluation of both donor renal function and recipient cardiovascular state.
authors.affiliation: Department of Nephrology and Transplantation, University Hospitals of Nice, 30 Avenue de la Voie Romaine, 06000 Nice, France.
authors.forename: S
authors.initials: S
authors.lastname: Mzoughi
authors.forename: L
authors.initials: L
authors.lastname: Albano
authors.forename: M
authors.initials: M
authors.lastname: Criste
authors.forename: R
authors.initials: R
authors.lastname: Aoudia
authors.forename: B
authors.initials: B
authors.lastname: Seitz
authors.forename: P
authors.initials: P
authors.lastname: Dahan
authors.forename: H
authors.initials: H
authors.lastname: Vacher-Copponat
authors.forename: P
authors.initials: P
authors.lastname: Merville
authors.forename: L
authors.initials: L
authors.lastname: Rostaing
authors.forename: G
authors.initials: G
authors.lastname: Mourad
authors.forename: M
authors.initials: M
authors.lastname: Gigante
authors.forename: E
authors.initials: E
authors.lastname: Cassuto
mesh_terms: D000368:Aged; D002102:Cadaver; D002423:Cause of Death; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D008487:Medical History Taking; D018579:Patient Selection; D012189:Retrospective Studies; D013997:Time Factors; D014019:Tissue Donors / Q000706:statistics & numerical data*; D016896:Treatment Outcome
chemical_list: D003404:Creatinine